Alkyne-aryl phosphodiesterase-4 inhibitors

Details for Australian Patent Application No. 2002322940 (hide)

Owner Merck Frosst Canada Ltd.

Inventors Laliberte, Sebastien; Girard, Mario; Hamel, Pierre; Friesen, Richard; Guay, Daniel

Agent Spruson & Ferguson

Pub. Number AU-B-2002322940

PCT Number PCT/CA02/01324

PCT Pub. Number WO2003/018579

Priority 60/316,093 29.08.01 US

Filing date 27 August 2002

Wipo publication date 10 March 2003

Acceptance publication date 1 March 2007

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 31/436 (2006.01)

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/02 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 11/14 (2006.01) Drugs for disorders of the respiratory system

A61P 11/16 (2006.01) Drugs for disorders of the respiratory system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 27/02 Drugs for disorders of the senses

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 60/316,093 29.08.01 US

5 June 2003 Application Open to Public Inspection

  Published as AU-B-2002322940

16 March 2006 Assignment before Grant

  Merck Frosst Canada & Co. The application has been assigned to Merck Frosst Canada Ltd.

1 March 2007 Application Accepted

  Published as AU-B-2002322940

28 June 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002322941-OXYGEN DOPING OF JOSEPHSON JUNCTIONS

2002322939-WHEEL PULLING APPARATUS